NIBIB-supported researchers have developed a smart nanoprobe designed to infiltrate prostate tumors and send back a signal using an optical imaging technique known as Raman spectroscopy. The new probe, evaluated in mice, has the potential to determine tumor aggressiveness and could also enable sequential monitoring of tumors during therapy to quickly determine if a treatment strategy is working.
A multidisciplinary group of NIH-funded scientists have successfully captured real-time, high-resolution images of the developing mouse placenta during the course of pregnancy. Their technique, which combines a surgically implanted window with a next-generation imaging system, provides key insight into placental development under both healthy and pathological conditions.
Using a circuit-based system, scientists determined the ideal transcription factor levels to promote the successful reprogramming of fibroblasts into induced pluripotent stem cells.
What if bacteria—which love to grow deep inside tumors—could guide cancer therapies directly to their target? NIH-funded researchers have engineered a bacterial strain to “light up” tumors so that reprogrammed T cells, drawn like a moth to a flame, can find and destroy them. Their preclinical treatment could potentially be effective against any solid tumor type.
A collaborative team of NIH-funded researchers is developing a way to obtain DNA shed from brain tumors using focused ultrasound. Their first-in-human study could be an important step towards improving the way brain tumors are diagnosed.
NIH-funded researchers created nanoparticles that could deactivate immune cells and prevent severe allergic reactions in mice. The findings could lead to new approaches to prevent allergies and anaphylaxis in people. Source: NIH Research Matters
A first-of-its-kind vibrating pill that significantly reduces food consumption by mimicking the feeling of fullness was crafted by researchers at the Massachusetts Institute of Technology, and they believe the pill can be used as a cheaper, noninvasive option to treat obesity and other weight-related illnesses. Source: Forbes
Researchers at Stanford revealed a novel physical mechanism that breast cancer cells use to break out and become invasive. They found that, in addition to established chemical methods of degrading the basement membrane, cancer cells work as a group to physically deform and tear through the basement membrane barrier. Source: Stanford News
Dendritic cells are key orchestrators of the immune response, but most vaccination strategies don’t effectively target them. NIBIB-funded researchers have developed biodegradable nanoparticles that are designed to deliver mRNA cargo to dendritic cells in the spleen. Combined with another type of immunotherapy, their vaccine had robust antitumor effects in multiple mouse models.